Warning! GuruFocus detected
4 Severe warning signs
with OPT.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
Business Description
Opthea Ltd
NAICS : 325412
SIC : 2834
ISIN : US17254C1009
Share Class Description:
OPT: ADRDescription
Opthea Ltd operates in one industry being the medical technology and healthcare. It is focused on developing biological therapeutics for eye diseases. The company is developing a novel biologic therapy, OPT-302, for the treatment of eye diseases. Its products are based on the intellectual property portfolio covering Vascular Endothelial Growth Factors C and D and R3 targets. Opthea's development activities are based on an intellectual property portfolio covering key targets Vascular Endothelial Growth Factors VEGF-C, VEGF-D and VEGF Receptor-3 for the treatment of diseases associated with blood and lymphatic vessel growth, as well as vascular leakage. The company geographically operates Australia and United States.
Financial Strength
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.84 | |||||
| Equity-to-Asset | -1.16 | |||||
| Debt-to-Equity | -0.93 | |||||
| Debt-to-EBITDA | -0.73 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | -5.88 | |||||
| Beneish M-Score | -2.39 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | -38.2 | |||||
| 3-Year EPS without NRI Growth Rate | -48.7 | |||||
| 3-Year FCF Growth Rate | -33.1 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 1783.67 |
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 47.1 | |||||
| 9-Day RSI | 39.25 | |||||
| 14-Day RSI | 39.28 | |||||
| 3-1 Month Momentum % | 17.65 | |||||
| 6-1 Month Momentum % | 15.87 | |||||
| 12-1 Month Momentum % | 17.65 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.57 | |||||
| Quick Ratio | 1.57 | |||||
| Cash Ratio | 1.44 | |||||
| Days Sales Outstanding | 5504.05 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -39.2 | |||||
| Shareholder Yield % | -51.49 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Operating Margin % | -210542.54 | |||||
| Net Margin % | -288689.55 | |||||
| FCF Margin % | -82510.23 | |||||
| ROA % | -152.05 | |||||
| ROIC % | -573.96 | |||||
| 3-Year ROIIC % | -1369.83 | |||||
| ROC (Joel Greenblatt) % | -202849.2 | |||||
| ROCE % | -214.33 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-EBIT | -2.3 | |||||
| EV-to-Forward-EBIT | -4.37 | |||||
| EV-to-EBITDA | -2.3 | |||||
| EV-to-Forward-EBITDA | -4.37 | |||||
| EV-to-Revenue | 5812.89 | |||||
| EV-to-Forward-Revenue | 279.45 | |||||
| EV-to-FCF | -6.79 | |||||
| Earnings Yield (Greenblatt) % | -43.48 | |||||
| FCF Yield % | -15.52 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:OPT
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return %
Total Annual Return %
Opthea Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 0.088 | ||
| EPS (TTM) ($) | -2.252 | ||
| Beta | 1.43 | ||
| 3-Year Sharpe Ratio | 0.19 | ||
| 3-Year Sortino Ratio | 0.32 | ||
| Volatility % | 84.74 | ||
| 14-Day RSI | 39.28 | ||
| 14-Day ATR ($) | 0.249243 | ||
| 20-Day SMA ($) | 3.53135 | ||
| 12-1 Month Momentum % | 17.65 | ||
| 52-Week Range ($) | 1.79 - 6.3 | ||
| Shares Outstanding (Mil) | 153.91 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Opthea Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Opthea Ltd Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Opthea Ltd Frequently Asked Questions
What is Opthea Ltd(OPT)'s stock price today?
The current price of OPT is $3.41. The 52 week high of OPT is $6.30 and 52 week low is $1.79.
When is next earnings date of Opthea Ltd(OPT)?
The next earnings date of Opthea Ltd(OPT) is 2025-08-29 Est..
Does Opthea Ltd(OPT) pay dividends? If so, how much?
Opthea Ltd(OPT) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers